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We have been using a murine model of graft-vs.-host disease (GVHD) 1 induced 
across minor histocompatibility antigen (MiHA) barriers to study the immuno- 
logical changes that occur during chronic GVHD induced by bone marrow (BM) 
transplantation (1).  In our system, we inject B10.D2 (H-2  d, mls b)  lymphocytes 
into irradiated BALB/c (H-2  d, mls b) recipients. These two strains are thus H-2- 
and  mls-identical, and  are  not  reactive  in  primary mixed  leukocyte reaction 
(MLR) cultures. This model system is very similar to human BM transplantation 
in which the donor and recipient are matched for HLA identity and nonreactivity 
in MLR (2,  3). 
Previously (4), we have shown that irradiated (600 rad) BALB/c recipients of 
B10.D2  spleen  cells develop a  chronic form of GVHD  that resembles sclero- 
derma. Furthermore, spleen cells taken from the GVH animals 10 d postinjection 
are almost totally unresponsive to mitogens (1). These spleen cells also suppress 
the proliferative response of normal spleen cells to mitogens (1). These changes 
are profound, and last for many months postinjection (5).  We have also shown 
(5) that, while this GVH suppression appears nonspecific and genetically unre- 
stricted, there are some peculiarities. Early (10-d) GVH suppressor cells are able 
to  suppress  the  mitogen  responses  of all  mouse  strains  tested,  except  for  a 
relatively weak suppression of the lipopolysaccharide (LPS) response of B10.D2 
(syngeneic with donor). By day 42, GVH suppressor cells are almost completely 
unable to suppress the LPS response of B 10.D2 spleen cells, while still being able 
to  suppress  the  mitogen  responses  of all  other  mouse  strains  (including the 
concanavalin A  [Con A]  response of B10.D2)  (5).  The cells that mediate this 
GVH suppression are not mature T  cells,  B cells,  or macrophages. They can be 
enriched in the less dense fractions ofpercoil gradients, but they show no natural 
killer reactivity. Therefore, they belong to the class of regulatory cells known as 
natural suppressor (NS) cells (6). 
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In this report,  we investigated the cellular requirements  for both the in  vivo 
induction  as well  as  the  in  vitro  expression  of this  GVH  NS  cell  suppression. 
While  donor  T  cells are necessary, they are not  sufficient in themselves, and a 
non-T  cell  population  is  also  required  for  maximum  induction  in  vivo.  The 
maximum expression  of NS  cell  suppression  in  vitro also  requires  T  cells.  At 
later  times,  when  GVH  suppressor  cells  are  losing  potency,  the  addition  of 
externally  generated  T  cell  signals  (Con  A  supernatant  [CAS])  allows  these 
suppressor cells to express suppressor function again. 
Materials and  Methods 
Mice.  BALB/c (H-2  d, mls b) were purchased from Cumberland View Farms, Clinton, 
TN. B10.D2/nSn  (H-2  d, mls b), C57BL/6 (H-2  d, mls b), and DBA/2 (H-2  d, mls a) were 
purchased from The Jackson Laboratory, Bar Harbor, ME. C3H/HeN (H-2  d, mls c) were 
purchased from the Charles  River Breeding  Laboratories, Wilmington,  MA.  All  mice 
were female and were used at 6-12 wk of age. 
Injection of Transplanted  Cells into Host Mice.  For the majority of experiments, spleen 
cells were pooled from donor B10.D2 or BALB/c mice. However, several experiments 
also used pooled thymus, lymph node (LN) (inguinal and axillary), or BM (from the femur 
and  tibia)  cells.  Erythrocyte-free cell suspensions were prepared by passage through  a 
stainless steel mesh screen and treatment with Tris-NH4CI solution,  followed by three 
washings in balanced salt solution (BSS).  After washing, a  total of 4  or 5  ×  107 trypan 
blue-excluding B10.D2 or BALB/c cells were injected intravenously in a volume of 1.0 
ml BSS into irradiated recipient BALB/c mice. BALB/c recipients of B10.D2 cells are 
called GVH mice. BALB/c recipients of BALB/c cells are called syngeneic controls. 
Irradiation  of Recipient Mice.  Recipient BALB/c mice were irradiated on day 0  with 
600 rad (from a 6°Co source [ 15 rad/min]). They were injected within 3 h after irradiation. 
After  irradiation,  all  mice  were  given  tetracycline  (Polytic,  250  rag/liter;  American 
Cyanamid Co., Wayne, N  J) in their drinking water for the first 14 d. All mice were kept 
in a laminar flow hood for the duration of the experiment. 
Experimental  Spleen  Cell Suspensions  and Medium.  At  various  times after injection, 
recipient BALB/c mice were killed,  their spleens removed and pooled (a minimum of 
three mice per group).  Erythrocyte-free cell suspensions were prepared as above. After 
washing, the cells were counted and tested for their ability to proliferate in response to 
mitogens, and for their ability to suppress normal mitogen responses. 
All  cultures were carried out in tissue culture medium (TCM), which is RPMI  1640 
(Flow  Laboratories  Inc.,  McLean,  VA)  supplemented  with  200  mM  L-glutamine,  100 
U/ml penicillin, 100 #g/ml streptomycin, 5 ×  10  -5 M 2-mercaptoethanol, 10 mM Hepes, 
and 5% heat-inactivated fetal bovine serum (Irvine Scientific, Santa Clara, CA). Cultures 
were carried out at 37°C in a humidified atmosphere of 5% CO2. 
Mitogen  Proliferation.  Mitogens  used  were  Con  A  (Jackbean;  Calbiochem-Behring 
Corp., San Diego, CA), at a  final concentration of 4 #g/ml, and LPS (S. typhosa; Difco 
Laboratories, Detroit, MI), at a final concentration of 10 t~g/ml.  Spleen cells from either 
GVH, syngeneic control, or normal mice were placed in 96-well flat-bottom microtiter 
plates (Costar, Cambridge, MA) at 2.5 ×  105 cells/well in 200 #1 of TCM (plus mitogen). 
They were cultured for a total of 72 h, the final 18 h with 1 t~Ci of [SH]thymidine (in 10 
#1  TCM).  Cells  were  harvested,  and  [3H]thymidine  uptake  was  estimated  by  liquid 
scintillation counting. 
Suppression of  Mitogen Responses by GVH Spleen Cells.  In mixing experiments that tested 
the suppressive ability of GVH spleen cells,  2.5  ×  10  ~ normal spleen cells and mitogen 
were cocultured with various numbers of GVH spleen cells (usually titrated from 4 ×  104 
to 2.5  ×  10 ~ cells/well). The total volume was maintained at 200 tA/well  (plus mitogen). 
These cells were cultured and pulsed as above. 
In all proliferation and suppression experiments, each test group was done at least in MAIER  ET  AL.  981 
triplicate. SD within each replicate was always <10% of the mean, except when the mean 
was near zero. 
Anti-Thy-l.2 Plus Complement (C') Treatment.  To eliminate Thy-bearing cells, 3 x  107 
spleen cells were incubated for 60 rain at 4°C with a  1:250 dilution of anti-Thy-l.2 (New 
England Nuclear, Boston, MA) in BSS containing 0.3% bovine serum albumin. The cells 
were then washed once, resuspended in  1 mi of BSS plus 0.3% bovine serum albumin 
with guinea pig C' (Gibco Laboratories, Grand Island, NY) at a final dilution of 1:15, and 
incubated a further 60 min at 37°C. After treatment, the cells were washed three times, 
and the cell concentration readjusted in TCM.  This treatment removes, from normal 
spleen cell populations, the proliferative response to Con A, but not to LPS. 
Nylon Wool (NW) Enrichment of LN T Cells.  LN cells were passed through an  NW 
column to enrich for T  cells, as described by Julius, et ai. (7). Briefly, 2 X 108 LN cells at 
5 ×  107 cells/ml in TCM were applied to 1.8 g of prewashed NW in a 30-ml syringe. The 
column was incubated for 60 rain at 37°C, then cells were eluted from the column with 
37°C TCM. ~25% of the cells were recovered by elution. 
Con A Supernatant.  Lectin-free CAS was produced using BALB/c spleen cells. Spleen 
cells were resuspended at  107 ceils/ml in  TCM with  Con  A  (4  ug/mi).  50  ml  of this 
suspension were then incubated at 37 °C in a 75-cm  2 tissue culture flask (Falcon Labware, 
Oxnard, CA).  After 2 h, the medium was gently poured off and the flask gently washed 
three times with TCM (without Con A). 50 ml of fresh TCM (without Con A) was then 
added to the flask, and incubation was continued for an additional  18 h at 37°C. CAS 
was then harvested and centrifuged to remove cells. The CAS was concentrated using an 
Amicon filter (cutoff of 10,000 tool wt) to I0 times its original concentration. Concen- 
trated CAS was stored at -70°C until use. It was then reconstituted to its original volume 
with TCM, and used at final dilutions in culture of 1:10 (i.e. 20 ttl in a total of 200/zi), 
1:30, and 1:90. 
Lectin-free CAS was assayed for its ability to maintain the interleukin 2-dependent T 
cell line CTLL-20 in culture, and for its lack of iectin by inability to stimulate normal 
BALB/c spleen cells in culture. 
Results 
Requirement  of T  Cells for In  Vivo  Induction  of GVH Suppression.  We  have 
previously shown  (4)  that  irradiated  (600  rad)  BALB/c  mice develop chronic 
GVHD  when  injected  with  MiHA-disparate  B10.D2  spleen  cells.  10  d  after 
injection, there is pronounced splenomegaly,  the recipient spleen cells are hy- 
poresponsive  to  mitogens,  and  also  suppress  normal  spleen  cell  proliferative 
responses to mitogens (1, 4-6). 
The first series of experiments were designed to see if T  cells in the inoculum 
are  required  for  the  in  vivo  generation  of immune  hyporesponsiveness  and 
suppression.  Irradiated  BALB/c  hosts  were  injected  with  allogeneic  B10.D2 
spleen cells, either untreated, or treated with anti-Thy-l.2 plus C' to remove T 
cells.  As  shown  in  Table  I,  spleen  cells  from  mice  that  had  received  T  cell- 
depleted B10.D2 spleen cells (group E) were unable to induce suppression, while 
spleen  cells  from  mice  that  were  injected  with  either  untreated  or  C'  only- 
treated  B10.D2  spleen cells (groups  C  and  D)  were able  to suppress  mitogen 
responses. Also, while far from normal, the mitogen responses of the spleen cells 
from the mice injected with the T-depleted B10.D2 spleen cells (group E) were 
greatly elevated when compared to those given by the untreated or C'  control 
B10.D2 spleen cell-injected mice (groups C and D). 
Finally, it should be noted that the viable cell recovery per spleen of BALB/c 
host mice injected with T-depleted B 10.D2 spleen cells (group E) was substantially 
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TABLE  I 
T Cells Are Required in the BIO.D2 Spleen Cell Inoculum to Induce Suppression in BALB/c 
Hosts 
Donor cell treat-  Viable cell re-  Con A-in-  LPS-induced  Suppression  of  Suppression  of 
Con A-in-  cover  T per  duced prolif-  prolifera-  Group  Cell type injected*  ment  $  spleen!  eration  I  tion  I  duced prolifer-  LPS-induced 
ation  W  P  roliferationq 
cpm 
A  Normal BALB/e  --  1.7 ×  108  325,000  110,00O  356,000  117,000 
B  None  --  5 ×  106  98.000  4,000  333,000 (6)  90,000 (23) 
C  BI0.D2  --  1.01 ×  l0  s  500  200  5,000 (99)  4,400 (96) 
D  B10.D2  C'  8.0 X l0  T  400  2,000  45,000 (87)  18,000 (84) 
E  BI0.D2  anti-Thy + C'  2.2 ×  l0  T  31,000  36,000  359,000 (-1)  98,000 (17) 
F  BALB/c  --  2.9 ×  l0  T  143,000  29,000  348,000 (2)  96,000 (18) 
G  BALB/c  C'  3.3 ×  107  123,000  29,000  363,000 (-2)  93,000 (20) 
H  BALB/c  anti-Thy + C'  2.3 ×  107  81,000  28,000  303,000 (-2)  22,000 (30) 
BALB/c (600 rad) mice were injected on day 0, and their spleens were assayed 10 d later. 
* 5 ×  107 of the indicated spleen cells were injected into BALB/c hosts on day 0. Normal BALB/c 
are mice neither irradiated nor injected. Experimental mice all received 600 rad. 
* Before injection, spleen cells were treated with anti-Thy-1.2 +  C' to remove T  cells. 
0 A  minimum of three mice per group were killed, their spleen cells were pooled, and the total 
number of viable cells per spleen was determined by trypan-blue exclusion. 
! 2.5 x  10 ~ cells/well +  4 #g/ml Con A or 10 ~g/ml LPS. 
i  105 GVH spleen cells were added to 2.5 x  105 normal BALB/c cells/well + Con A or LPS. Percent 
suppression (in parentheses) was calculated vs. 3.5 ×  105 normal BALB/c spleen cells/well with the 
appropriate mitogen. 
fact,  the  cell  recovery  is  about  the  same  as  seen  in  the  syngeneic  control 
BALB/c --~ BALB/c  mice (groups  F,  G,  and  H).  There  was also  substantial 
splenomegaly in  the mice that had received either the untreated or C'  only- 
treated allogeneic B10.D2 spleen cells. This is not readily apparent in the viable 
cell recovery because a  large percentage (50-70%)  of the total cell number in 
these suppressive spleens at this time are, in  fact, dead cells (our unpublished 
observations). 
Relative  Efficiency  of Cells from  Various  Lymphatic  Organs  in  Inducing  GVH 
Suppression.  Since the previous experiments had shown that T cells are required 
for the in vivo induction of GVH suppression (as well as maximum hyporespon- 
siveness  to  mitogens and  splenomegaly), the  next  series  of experiments was 
designed to test the ability of B10.D2 cells from either the spleen, BM, LN, or 
thymus to induce suppression in irradiated BALB/c hosts. As shown in Table II, 
those  mice that  had  been  injected with  either  BM  (group  D)  or  spleen  cells 
(group E) had many more viable spleen cells than animals injected with either 
thymus or LN cells (groups B and C, respectively). 
With regard to mitogen responsiveness, spleen cells from group E mice, which 
had received B10.D2  spleen cells, were unresponsive to both Con A and LPS. 
Group  D  mice, which had received BM cells, were relatively hyporesponsive, 
although comparable to those seen in the appropriate syngeneic control (group 
H). The spleen cells from mice that received thymus (group B) or lymph node 
(group C) were only moderately hyporesponsive. 
With regard to suppressive  abilities,  spleen cells from recipients of B10.D2 MAIER ET  AL.  983 
TABLE  II 
Source of BlO.D2 Cells Used to Induce Suppression in BALB/c Hosts 
Viable cell re-  Con A-induced  LPS-induced  Suppression of  Suppression of 
Group  Cell type injected*  cover,/per  Con A-induced  LPS-induced pro- 
spleen~:  proliferation!  proliferation!  proliferationl  liferation I 
cpm 
A  Normal BALB/c  1.6 X l0  s  257,000  91,000  329,000  101,000 
B10.D2 
B  Thymus  3 ×  I0  °  53,000  2,400  306,000 (7)  97,000 (4) 
C  LN  8 x  l0  s  37,000  65,000  291,000 (11)  53,000 (47) 
D  BM  9.0 x  l0 T  2,800  16,000  165,000 (50)  58,000 (42) 
E  Spleen  7.1 x  l0 T  400  700  9,300 (97)  5,000 (95) 
BALB/c 
F  Thymus  5 x  10  °  82,000  2,400  334.000 (-1)  108,000 (-7) 
G  LN  4 x  l0  s  208,000  27,000  324,000 (2)  91,000 (10) 
H  BM  1.1  X  10  s  9,500  20,000  302,000 (8)  92,000 (9) 
1  Spleen  3.8 x  l0 T  33,000  12,400  342.000 (-4)  83,000 (18) 
BALB/c (600 rad) mice were injected on day 0, and their spleens were assayed 10 d later. 
* 5  X  10  7  cells from  the indicated organ  were injected into  BALB/c hosts on day 0.  Normal 
BALB/c are mice neither irradiated nor injected. 
A minimum of three mice per group were killed, their spleens pooled, and the total number of 
viable cells per spleen was determined by trypan-blue exclusion. 
2.5 × 105 cells/well + 4 #g/ml Con A or 10 #g/ml LPS. 
! 105 GVH spleen cells were added to 2.5 × 10  ~  normal BALB/c cells/well + Con A or LPS. Percent 
suppression (in parentheses) was calculated vs. 3.5 x  105 normal BALB/c spleen cells/well with the 
appropriate mitogen. 
spleen cells (group E) suppressed normal lymphocyte proliferative responses to 
Con A and LPS. Spleen cells from BM-injected mice (group D) were moderately 
suppressive, but spleen cells from mice injected with LN or thymus cells (groups 
C  and  B) showed  little suppressive ability.  Fig.  1 shows a  typical titration with 
GVH or syngeneic control spleen cells in the suppression of the Con A  response 
of normal  BALB/c  spleen  cells.  2.5  x  105  normal  BALB/c  cells  are  easily 
suppressed by as few as 4  x  104 GVH spleen cells from mice that had received a 
B 10.D2 spleen inoculum, while recipients of BM cells are suppressive only at 1.0 
or  2.5  x  105  cells.  The  least  suppressive  cells  are  those  from  mice  receiving 
thymus or LN cells. In contrast, Fig.  1 B shows that spleen cells of the syngeneic 
controls are not significantly suppressive at any cocultured dose. 
Thus,  although  results  in  Table  I  show  that  T  cells are required  to induce 
hyporesponsiveness and suppression, the results in Table II and Fig.  1 show that 
neither thymus nor LN cells (both of which are mostly T  cells) are able to induce 
hyporesponsiveness and suppression alone. 
T and Non-T Cells Are Required for In Vivo Induction of  Maximum GVH Suppres- 
sion.  The previous results indicated that T  cells are required, but not sufficient 
for in  vivo induction of GVH suppression.  Also,  the injection of a  mixture of 
two cell populations (one [LN] rich  in  mature  T  cells,  the other [BM] rich  in 
stem  cells,  but  neither  capable  of inducing  maximum  suppression  alone)  pro- 
duced a synergistic effect in the induction of suppression (data not shown). We 
next asked  if a  purified T  cell population  could show  synergy with  a  T  cell- 
depleted  population  for the  in  vivo induction  of GVH  suppression.  This was 
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FIGUR~  1.  Titration of GVH spleen (:ell suppressive activity: Source of B10.D2 (:ells used to 
induce suppression in irradiated BALB/c hosts. BALB/c hosts were irradiated on day 0, then 
injected intravenously with 5 × 107 nucleated (:ells from either the thymus, LN, BM, or spleen 
of B10.D2 (A) or BALB/c (B) mice. 10 d later, three or more mice were killed per group, 
and their spleens were pooled. 25, 10, or 4 x  104 GVH or control spleen (:ells were cocuhured 
with 25 × 105 indicator spleen (:ells from BALB/c plus Con A (4 #g/ml) cuhures for 72 h, the 
final 18 h with [~H]thymidine (indicator culture  minus suppressors gave 295,000 cpm). The 
cultures were then  harvested and counted  for ~H incorporation,  cpm are expressed on the 
vertical axis, with the number of added GVH spleen cells on the horizontal axis. 
cells depleted of T  cells by anti-Thy-1.2 plus C' treatment, and B 10.D2 LN cells 
enriched for T  cells by passage through an NW column. 
Table III shows the  results.  When  untreated  B10.D2  spleen cells were given 
to irradiated BALB/c recipients (group B), the recipient spleens were unrespon- 
sive to  Con  A  and  LPS,  and  also suppressed  the  Con  A  and  LPS  responses of 
normal cells.  If the donor graft was anti-Thy-treated spleen cells (group C), the 
unresponsiveness and  suppression  were  much  less evident.  Donor  NW  nonad- 
herent  LN cells (group D) induced  only modest unresponsiveness and suppres- 
sion. However, mixtures of T-depleted spleen and nonadherent LN cells (groups 
E-G) produced  significant unresponsiveness, and potent suppression.  As few as 
.5% LN T  cells added to 95% T-depleted spleen cells produced more unrespon- 
siveness and  more suppression  than  could  be expected  from the  sum  of their 
separate abilities. 
Genetics of Suppressive Ability of GVH Spleen Cells.  The next series of experi- 
ments was designed to explore the role of T  cells in the expression of this GVH- 
induced suppression in vitro. MAIER  ET  AL. 
TABLE III 




Anti-Thy-  Viable cell  Con A-in-  LPS-in-  SuppressiOncon  A-in-°f  SuppressiOnof  LPS-in- 
Untreated spleen  1.2 +  C'-  NW-NA  recovery  duced pro-  duced pro-  duced prolif-  duced prolif- 
cells  treated  LN ceils  per spleen  liferation!  liferation  !  eration!  erationl 
spleen cells 
cpm 
A  Normal BALB/c  1.35 x  ! 0 s  311,000  92,000  356.000  93,000 
B  4 ×  107 B10.D2  8.3 x  107  400  300  35,000 (90)  5,000 (95) 
C  --  4x  IO  T  --  3.1 x  l0  T  39,000  41,000  320,000(10)  69,000(25) 
D  --  --  2 x  l0  T  4  x  10  e  18,000  4,300  264,000 (26)  52,000 (43) 
E  --  2  x  l0  T  2 x  l0  T  5.1 ×  l0  T  600  300  85,000 (76)  5,000 (95) 
F  --  3.3 ×  107  6.7 x  106  6.9 ×  l0  T  600  400  67,000 (81)  9,000 (90) 
G  --  3.8 X  l0  T  2.2 x  106  7.0 x  l0  T  400  1,300  83,000 (77)  26,000 (72) 
H  --  --  --  6 X  106  149,000  12,000  346,000 (3)  76,000 (18) 
BALB/c (600 rad) mice were injected on day 0, and their spleens were assayed 10 d later. 
* B10.D2 cells of the indicated type were injected into BALB/c hosts on day 0. Normal BALB/c are 
mice neither irradiated  nor injected. The cell types injected were either untreated spleen cells or 
anti-Thy-l.2 + C'-treated spleen cells (i.e. T  cell-depleted),  or NW-nonadherent  (NW-NA) LN 
cells (i.e. T cell-enriched),  or a mixture of the latter two. 
* A minimum of three mice per group were killed, their spleens cells were pooled, and the total 
number of viable cells per spleen was determined by trypan-blue exclusion. 
| 2.5 x  105 cells/well + 4 #g/ml Con A or 10 #g/ml LPS. 
I 105 GVH spleen cells were added to 2.5 × 105 normal BALB/c cells/well + Con A or LPS. Percent 
suppression (in parentheses) was calculated vs. 3.5 × 105 normal BALB/c spleen cells/well with the 
appropriate mitogen. 
Previously (5),  we have shown  that  both  10- and  42-d  GVH  spleen cells are 
relatively nonspecific in their ability to suppress the mitogen response of normal 
lymphocytes.  It was apparent  that,  while  both  10- and  42-d  GVH  spleen  cells 
could suppress the Con A  responses of all mouse strains tested by almost 100%, 
they were not able to do the same with LPS responses. Day 10 GVH spleen cells 
were weak in suppressing a  B10.D2  (syngeneic to donor) LPS response. By day 
42,  GVH spleen cells were unable to suppress the B10.D2  LPS response, while 
still able to suppress other  LPS responses.  This is shown in Fig.  2.  This figure 
represents the selective loss with time of the ability to suppress a  B 10.D2 or self 
LPS response  (GVH spleen  cells are almost entirely  of donor  origin,  data  not 
shown).  This  result  suggested  that  maximum  in  vitro  expression  of  NS  cell 
activity may require  T  cell signals.  In the suppression  of LPS responses, T  cell 
activation would have to occur, probably through  MLR-type reactions, while in 
the case of suppression of Con A responses, the added mitogen itself would allow 
for T  cell activation,  and therefore all strains could be suppressed.  This would 
be most apparent  at  later  times during  GVHD, when  the  GVH  NS  cells  have 
become somewhat quiescent. 
Removal of T Cells from Normal Responder Population in Mitogen Assay Decreases 
Ability of 40-d  GVH Spleen  Cells to Suppress.  This  hypothesis implies that  if T 
cells are removed from the normal responding indicator population (one where 
B10.D2  can act as a  stimulus  for an  MLR),  then  the  suppression generated by 
relatively  quiescent  40-d  GVH  suppressor  cells  should  be  less  than  the  same 
culture  containing  normal  T  cells.  Results  from  one  such  LPS  suppression 
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FXC.trRE 2.  Suppressive ability  over  time  of spleen  cells  from  B10.D2  ~  BALB/c  GVH 
animals towards normal B10.D2 (A) or BALB/c (B) lymphocyte proliferative responses to the 
mitogens Con A or LPS. BALB/c hosts were irradiated on day 0  with 600 rad, then injected 
intravenously with 5  ×  107 B10.D2 spleen cells. At various times subsequently, three or more 
mice per day were killed, and  their spleens were pooled. 2.5  ×  105  GVH spleen cells were 
cocultured with 2.5 x  105 BALB/c (syngeneic to host) (B) or BI0.D2 (syngeneic to donor) (A) 
spleen cells plus either  Con  A  (4  #g/ml)  or  LPS (10  #g/ml)  for  72  h,  the final  18  h  with 
['H]thymidine. The cultures were then harvested and counted for ~H incorporation. Percent 
control response was calculated vs. the 2.5  ×  105 normal BALB/c or B10.D2 Con A  or LPS 
proliferative response, whichever was appropriate.  The  percent of control  response is ex- 
pressed on the vertical axis, with the time in days postirradiation/injection on the horizontal 
axis. 
TABLE  IV 
Removal ofT Cells  from Normal Spleen Cell Population Reduces Ability of GVH Spleen Cells 
to Suppress 
Anti-Thy-1.2  40-d GVH  Suppression of LPS-in- 
Group  Responder population  +  C' treat-  spleen cells  duced proliferation 
ment  added 
cpm 
A  B10.D2  -  -  93,000 
B  -  +  76,000 (18) 
C  +  -  89,000 
D  +  +  77,000 (13) 
E  C57BL/6  -  -  121,000 
F  -  +  64,000 (47) 
G  +  -  102,000 
H  +  +  84,000 (18) 
2.5 x  105 normal spleen cells (with or without anti-Thy-1.2 +  C' treatment to remove T  cells) were 
cocuhured  with 2.0  x  l0 s 40-d  B10.D2  ~  BALB/c (600  rad)  GVH  spleen cells with  10 #g/ml 
LPS. 
* Percent suppression (in parentheses) was calculated  vs.  4.5  ×  105  normal spleen cell population 
(with or without anti-Thy-l.2 +  C' treatment). MAIER  ET  AL.  987 
from the normal B10.D2 population had little effect on the ability of B10.D2 ---, 
BALB/c GVH spleen cells to suppress (18 ---* 13%),  the same treatment caused 
the  suppressive  ability  of  GVH  spleen  cells  to  fall  from  47%  to  18%  with 
C57BL/6  populations.  This result shows that T  cells are important for in vitro 
expression of GVH suppression; in this case, the C57BL/6 T  cells responding to 
the B10.D2 ~  BALB/c GVH spleen ceils generate enough T  cell signals to allow 
suppression to express itself (group F vs. E). When T  cells are removed, suppres- 
sion  is  greatly  diminished  (group  H  vs.  G).  When  B10.D2  ---* BALB/c  GVH 
suppressor cells are cultured with B10.D2  responder cells plus LPS (groups A- 
D),  there  are  no  MLR  signals  to  activate  the  suppressors,  and  removal  of 
responder T  cells makes no difference. 
CAS Enhances Suppressive Ability of 40-d GVH Spleen Cells.  If GVH suppressor 
cells  are  taken  at  40  d  postinjection,  when  the  suppressor  cells  are  relatively 
quiescent (see Fig.  2  and ref.  5) and are added  to the  LPS response of normal 
spleen cells plus lectin-free CAS, the suppression should be more than the same 
culture minus lectin-free CAS. The results in Fig.  3 show that this is indeed the 
case. 
The  suppressive  ability  of the  40-d  GVH  spleen  cells  roughly  parallels  the 
proliferative responses in either a  1- or 2-way MLR between normal B10.D2 and 
these  three  strains  (i.e.  little  suppression  of B10.D2,  moderate  suppression  of 
C57BL/6, and good suppression of DBA/2  LPS responses). The addition of the 
CAS  (in  itself not  suppressive  of normal  LPS  responses)  greatly  enhances  the 
suppressive ability of these  GVH  suppressor  cells.  In fact, with a  1:10  or  1:30 
dilution  of CAS,  the  suppression  of all three  strains becomes essentially equal, 
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FIGtrRV 3.  CAS enhances the suppressive ability of 40-d GVH spleen cells. BALB/C hosts 
were irradiated  on day 0, then injected intravenously with 5 x  107 B10.D2 spleen cells. 40 d 
later, spleens were taken and pooled. 2.0 ×  105 GVH spleen cells were cocultured with 2.5 × 
5  10  normal spleen cells from the various mouse strains plus LPS (10 #g/ml) for 72 h, the final 
s  18 h with [ Hlthymidine.  Some of these cultures were done with a  I:10, 1:30, or 1:90 final 
dilqtion of CAS (not suppressive, at these dilutions, of normal LPS responses). The cultures 
s  were then harvested and counted for  H incorporation. Percent control response was calculated 
vs. the 4.5 x  105 normal spleen cell LPS proliferative responses. The percent control response 
is expressed on the vertical axis, with the various strains used on the horizontal axis. 988  GRAFT-VS.-HOST  DISEASE-INDUCED  NATURAL  SUPPRESSOR  CELLS 
phocytes from any strain if the proper T  cell signals are present (from the CAS 
in this case). 
Discussion 
These experiments involve a  routine GVHD model system where irradiated 
BALB/c recipients are injected with H-2- and mls-identical, but MiHA-disparate 
B10.D2  lymphocytes. This results in a  chronic form of GVHD.  Splenomegaly 
occurs early in these animals (4), although with time the spleens gradually empty 
of lymphocytes (5).  The spleen cells taken from these mice are hyporesponsive 
to both  Con  A  and  LPS,  and suppress  normal spleen cell responses to  these 
mitogens (1, 5). The suppressor cells are not mature T  cells, B cells, or macro- 
phages, but belong to a class called natural suppressor (NS) cells (6). 
B10.D2 spleen cells injected into irradiated BALB/c recipients induce spleno- 
megaly, mitogen unresponsiveness, and suppression.  However, B10.D2  spleen 
cells depleted of T cells by anti-Thy-1.2 plus C' treatment induce no splenomeg- 
aly, only moderate mitogen hyporesponsiveness, and little,  if any, suppressive 
activity in the recipient spleen cells (Table I).  This shows the absolute require- 
ment of T ceils in the in vivo development of this GVH suppression. Nevertheless, 
the results of Table II show that B10.D2 thymus or LN cells alone cause little if 
any suppression. This is not unexpected with thymocytes, as they are primarily 
immature  T  cells  that  may  be  unable  to  respond  well  to  BALB/c  MiHA. 
However, LN cells are primarily mature T  cells that are capable of causing a 
fatal  GVHD  in  this  system (our unpublished  observation)  yet do  not  induce 
suppression. Thus, T cells are required for in vivo induction of GVH suppression, 
but they are not sufficient. 
Further experiments showed that T  cells interacted with a non-T cell popula- 
tion  in  the inoculum to  induce the GVH  suppression  (Table  III).  A  B10.D2 
spleen cell population depleted of T  cells showed tremendous synergism with a 
T cell-enriched LN cell population in the in vivo induction of GVH suppression. 
As few as 2.2 x  106 (5%) NW nonadherent B10.D2 LN cells injected with 3.8 x 
107 (95%) anti-Thy plus C'-treated B 10.D2 spleen cells produced near-maximal 
suppressive activity. Thus, it seems that although T  cells are required (but not 
sufficient) for  in  vivo  induction  of GVH  suppression,  only a  relatively small 
number of them are sufficient for maximum induction. Preliminary experiments 
indicate that the cell population with which the T  cells synergize is a non-T, non- 
B, and nonmacrophage population. 
Previous results (5) show the nonspecificity of these GVH suppressor cells at 
days 10 and 42,  but there was a  selective loss with time of the ability of GVH 
spleen cells to suppress  a  B10.D2  (self) LPS response while still  being able to 
suppress the LPS and Con A responses of all other strains, including the Con A 
response of B10.D2 (Fig.  2).  However, this inability to suppress a  B10.D2  LPS 
response can be overcome by the addition of CAS to the cultures (Fig.  3).  In 
fact, CAS enhances the suppressive ability of GVH suppressor cells in general. 
These results have led us to  the following hypothesis:  NS cells are derived 
from the donor inoculum. Their proliferation and maturation into functional 
NS cells require an immunocompromised host (1, 5), as well as T  cell signals. T 
cell signals are also necessary for maximum suppression by NS  cells in  vitro. MAIER ET  AL.  989 
These  NS cells then  inhibit  the  proliferation  of stimulated  cells.  In  the  GVH 
mice, the immunocompetent donor B10.D2 T  cells react with a large number of 
aIlogeneic BALB/c host determinants, thus producing large amounts of activated 
T  cell signals for an extended period of time.  Activated T  cell signals expand 
the NS cell population also derived from the donor. This sequence explains the 
need  for  both  T  cells and  non-T  cells in  the  donor  B10.D2  inoculum.  This 
mechanism also explains the progressive loss of cells in the spleens of these GVH 
animals (5).  As host cells respond to various antigens,  the NS cells inhibit  their 
proliferation,  and  consequently,  fewer and  fewer cells survive.  This  may also 
explain in part the increased susceptibility to infections during GVHD (8-10). T 
cells responding to foreign antigens  may actually be functionally eliminated by 
NS cells. 
This mechanism also explains the apparent selective loss with time of the ability 
of B 10.D2 ~  BALB/c GVH suppressor cells to suppress a B 10.D2 LPS response. 
At a later time in this model system (e.g. the 40 d used in this paper), the NS cell 
population would be relatively quiescent because of lowered levels of activated 
T  cell signals in vivo, as most reactive T  cells will have been inhibited/eliminated 
by this time. However, it may be that a population of T  cells becomes activated 
to a certain stage of development before the NS cell population becomes capable 
of their  downregulation,  this being one explanation  for the chronic  nature  of 
this type of GVHD. Therefore,  to show maximum  suppressive activity in vitro, 
T  cell activation is also needed. When these GVH NS cells are added to syngeneic 
B 10.D2 indicator spleen cells with LPS, there is little if any T  cell activation, and 
therefore  only minimal  suppression.  However, if allogeneic  indicator  lympho- 
cytes are used with LPS, then T  cells in the responding population can recognize 
the foreign determinants present on the GVH (B10.D2) population, resulting in 
T  cell  signal production,  followed by activation  of NS cells,  and  inhibition  of 
allogeneic LPS responses. The need for T  cells in the normal population is shown 
in Table IV, where the LPS response of a T  cell-depleted C57BL/6 population 
was much less suppressed than  one in which T  cells are present.  In the case of 
the NS cell suppression of a Con A response, recognition of antigenic differences 
is not necessary, because Con A  activates T  cells in large numbers.  Therefore, 
B10.D2 NS cells are able to suppress a  syngeneic B10.D2 Con A  response, but 
not an LPS response.  Also, the addition of externally-generated  T  cell signals, 
in the form of CAS, can turn a situation where little or no suppression is found 
(i.e. suppression by 40-d GVH NS cells of a B10.D2 LPS response) to a situation 
where maximum suppression is possible (Fig. 3). Preliminary work indicates that 
CAS  functions  by activating  the  NS cells, not just  by causing  the  NS cells to 
proliferate (although this activity may also be attributed to CAS [ 11 ]). 
We  have  shown  in  previous  work  (5,  6)  on  this  GVH  system  that  the 
BALB/c --* BALB/c syngeneic control mice also show some hyporesponsiveness 
and suppression.  Although  this suppression  is much  smaller in  magnitude  and 
more transient than the GVH suppression (5), the effector suppressor cell is also 
a  NS  cell  (6).  Syngeneic  suppression  and  GVH  suppression  may  in  fact  be 
instances  of the  same  basic  mechanism,  as  outlined  above.  In  the  syngeneic 
control  mice,  there  should  be  few activated  T  cell  signals  generated  by cells 
reacting to foreign determinants,  although it is possible that some signals could 990  GRAFT-VS.-HOST  DISEASE-INDUCED  NATURAL SUPPRESSOR  CELLS 
be generated by T  cells reacting to increased levels of various syngeneic differ- 
entiation antigens which occur during the repopulation that follows irradiation. 
This GVH suppression appears to be similar to that found in other systems 
where BM/lymphoreticular cells are rapidly proliferating: in neonatal mice (12), 
in adult mice or humans given total lymphoid irradiation (13, 14), with irradiation 
and autologous BM transplants in dogs (15), and after 89Sr (16) or cyclophospha- 
mide treatment in mice (17).  In these cases, nonspecific suppressors of normal 
cell proliferation have been found, and these suppressors bear the phenotype of 
natural suppressor (or null) cells (13-15,  17,  18). Thus, it appears that NS cells 
may be present in all cases where rapid proliferation of stem cells is occurring, 
including the case of B10.D2 ---* BALB/c (irradiated). 
It is possible that the suppressor mechanism we describe here could also be 
responsible for the inactivation/elimination of autoreactive cells that normally 
occurs in the neonate (19), or may occur in adult BM (20, 21), both of which 
have a relatively large NS cell component (13, 18). Early in T  cell development, 
either in the neonate or in adult BM, pre-T cells that react with self antigens 
would become activated to release signals into the local environment. The NS 
cells, a  natural component of these environments, could then respond to these 
activated T  cell signals and downregulate the autoreactive T  cell, with functional 
cional elimination being the result. 
Among the many interesting and potentially useful implications of this hypoth- 
esis is that it may further our understanding of the immunology of BM transplants 
and thus possibly widen the applications of this procedure (2, 3, 8, 22, 23). Also, 
if NS cells are involved, one may be able to prolong as well as enhance the 
neonatal period during which tolerance and graft acceptance can be induced. 
This may be possible by the addition of the proper T  cell signals.  Finally, in 
adults, procedures such as whole body irradiation followed by autologous (15), 
syngeneic (5,  6),  or  MiHA-disparate  (1,  5,  6)  reconstitution  seem to  open  a 
window of time during which NS cells can be activated, and allow a period for 
the induction of acquired immunological tolerance. According to our data, this 
window of opportunity may be opened wider by the addition of the proper T 
cell signals. 
Summary 
We have been studying the mitogen hyporesponsiveness and immunosuppres- 
sion induced in  chronic murine graft-vs.-host disease (GVHD) induced across 
minor histocompatibility (MiHA) barriers.  In this system, donor and recipient 
mice are major histocompatibility complex- and mls-identical, and are nonreac- 
tive in primary mixed leukocyte reactions. Spleen cells from B10.D2 (H-2  d, mls 
b) mice were injected into irradiated (600 rad) BALB/c (H-2  d, mls b) recipients. 
Recipient  spleen  cells  are  hyporesponsive  to  mitogens,  and  contain  natural 
suppressor (NS) cells. We investigated the cellular requirements for both the in 
vivo induction and the in vitro expression of this GVH suppression. T  cells are 
required in the graft, but they are not sufficient to induce suppression, and a 
non-T cell population is also required for maximum induction in vivo. T  cells 
are also required for the maximum expression of NS cell suppressive ability in 
vitro. Early in the course of GVH, the suppressor cells are able to suppress the MAIER ET  AL.  991 
Con  A  and  LPS  response  of all  mouse  strains  tested  (except  for the  relative 
difficulty in suppressing the B I0.D2 LPS response).  Later, they become almost 
completely unable to suppress the B10.D2  LPS response, while still being able 
to suppress the Con A and LPS response of all other strains tested (including the 
B10.D2 Con A  response). This inability to suppress a  B 10.D2 LPS response can 
be brought back to almost complete suppression by the addition of concanavalin 
A  supernatant (CAS). 
We present a  hypothesis to explain what  may be a  common mechanism  for 
GVH-induced suppression, total lymphoid irradiation-induced suppression, and 
neonatal tolerance. These situations all include rapidly proliferating lymphohe- 
matopoietic stem cell populations, and also have large numbers of NS cells. NS 
cells  can  suppress  proliferating  lymphoid populations,  and  their  development 
and activity are greatly enhanced by T  cell signals such as are supplied by donor 
T  cells in chronic GVHD. Thus,  NS cells may feed back on and downregulate 
self-reactive T  cells or T  cells responding to introduced foreign antigens. 
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